Gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders

Gene Therapy Workshop Faculty

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

We are in an emerging era of gene-based therapeutics with significant promise for rare genetic disorders. The potential is particularly significant for genetic central nervous system disorders that have begun to achieve Food and Drug Administration approval for select patient populations. This review summarizes the discussions and presentations of the National Institute of Mental Health-sponsored workshop “Gene-Based Therapeutics for Rare Genetic Neurodevelopmental Psychiatric Disorders,” which was held in January 2021. Here, we distill the points raised regarding various precision medicine approaches related to neurodevelopmental and psychiatric disorders that may be amenable to gene-based therapies.

Original languageEnglish (US)
Pages (from-to)2416-2428
Number of pages13
JournalMolecular Therapy
Volume30
Issue number7
DOIs
StatePublished - Jul 6 2022
Externally publishedYes

Keywords

  • gene therapy
  • neurodevelopment
  • psychiatric disorders

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders'. Together they form a unique fingerprint.

Cite this